255 related articles for article (PubMed ID: 19813185)
1. Frequency and predictors of nonalcoholic fatty liver disease in myotonic dystrophy.
Shieh K; Gilchrist JM; Promrat K
Muscle Nerve; 2010 Feb; 41(2):197-201. PubMed ID: 19813185
[TBL] [Abstract][Full Text] [Related]
2. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J
Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
[TBL] [Abstract][Full Text] [Related]
3. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects.
Musso G; Gambino R; Bo S; Uberti B; Biroli G; Pagano G; Cassader M
Diabetes Care; 2008 Mar; 31(3):562-8. PubMed ID: 18056890
[TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic fatty liver disease in severely obese subjects.
Gholam PM; Flancbaum L; Machan JT; Charney DA; Kotler DP
Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
[TBL] [Abstract][Full Text] [Related]
5. Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children.
Yoo J; Lee S; Kim K; Yoo S; Sung E; Yim J
Diabetes Res Clin Pract; 2008 Sep; 81(3):321-6. PubMed ID: 18571268
[TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.
Marchesini G; Bugianesi E; Forlani G; Cerrelli F; Lenzi M; Manini R; Natale S; Vanni E; Villanova N; Melchionda N; Rizzetto M
Hepatology; 2003 Apr; 37(4):917-23. PubMed ID: 12668987
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population.
Dassanayake AS; Kasturiratne A; Rajindrajith S; Kalubowila U; Chakrawarthi S; De Silva AP; Makaya M; Mizoue T; Kato N; Wickremasinghe AR; de Silva HJ
J Gastroenterol Hepatol; 2009 Jul; 24(7):1284-8. PubMed ID: 19476560
[TBL] [Abstract][Full Text] [Related]
8. The epidemiology of nonalcoholic fatty liver disease in adults.
Clark JM
J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S5-10. PubMed ID: 16540768
[TBL] [Abstract][Full Text] [Related]
9. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease.
Schwimmer JB; Deutsch R; Rauch JB; Behling C; Newbury R; Lavine JE
J Pediatr; 2003 Oct; 143(4):500-5. PubMed ID: 14571229
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures.
Zelber-Sagi S; Nitzan-Kaluski D; Halpern Z; Oren R
Liver Int; 2006 Sep; 26(7):856-63. PubMed ID: 16911469
[TBL] [Abstract][Full Text] [Related]
11. Relationships between estimates of adiposity, insulin resistance, and nonalcoholic fatty liver disease in a large group of nondiabetic Korean adults.
Sung KC; Ryan MC; Kim BS; Cho YK; Kim BI; Reaven GM
Diabetes Care; 2007 Aug; 30(8):2113-8. PubMed ID: 17475935
[TBL] [Abstract][Full Text] [Related]
12. Leptin and the metabolic syndrome in patients with myotonic dystrophy type 1.
Rakocevic Stojanovic V; Peric S; Lavrnic D; Popovic S; Ille T; Stevic Z; Basta I; Apostolski S
Acta Neurol Scand; 2010 Feb; 121(2):94-8. PubMed ID: 19804472
[TBL] [Abstract][Full Text] [Related]
13. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
[TBL] [Abstract][Full Text] [Related]
14. Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass.
Boza C; Riquelme A; Ibañez L; Duarte I; Norero E; Viviani P; Soza A; Fernandez JI; Raddatz A; Guzman S; Arrese M
Obes Surg; 2005 Sep; 15(8):1148-53. PubMed ID: 16197788
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD.
Kang H; Greenson JK; Omo JT; Chao C; Peterman D; Anderson L; Foess-Wood L; Sherbondy MA; Conjeevaram HS
Am J Gastroenterol; 2006 Oct; 101(10):2247-53. PubMed ID: 17032189
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease.
Harrison SA; Oliver D; Arnold HL; Gogia S; Neuschwander-Tetri BA
Gut; 2008 Oct; 57(10):1441-7. PubMed ID: 18390575
[TBL] [Abstract][Full Text] [Related]
17. Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors.
Koller T; Kollerova J; Hlavaty T; Huorka M; Payer J
Scand J Gastroenterol; 2012 Feb; 47(2):197-203. PubMed ID: 22182015
[TBL] [Abstract][Full Text] [Related]
18. Non-alcoholic fatty liver disease--a common and benign finding in octogenarian patients.
Kagansky N; Levy S; Keter D; Rimon E; Taiba Z; Fridman Z; Berger D; Knobler H; Malnick S
Liver Int; 2004 Dec; 24(6):588-94. PubMed ID: 15566509
[TBL] [Abstract][Full Text] [Related]
19. [Non-alcoholic fatty liver, high sensitivity C reactive protein and insulin resistance].
Zhou WD; Yang YL; Che ZH
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 33(7):565-70. PubMed ID: 18667766
[TBL] [Abstract][Full Text] [Related]
20. Effects of nonalcoholic fatty liver disease on the development of metabolic disorders.
Fan JG; Li F; Cai XB; Peng YD; Ao QH; Gao Y
J Gastroenterol Hepatol; 2007 Jul; 22(7):1086-91. PubMed ID: 17608855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
